Review
Open access
Oct 2026
Targeting Metabolic Drivers of Cardiovascular Disease: Insights for Therapeutic Innovation
Abstract Cardiovascular disease (CVD) remains the leading cause of death worldwide, and metabolic dysfunction is increasingly recognized as an important component of its pathophysiology. Clinical evidence supports a role for dysregulated lipid and glucose metabolism in atherosclerosis, heart failure, and cardiometaboli...
U. Kansakar, Malik Hyman, Enrico Volpe et al.
· Drug Design, Development and... · 0 citations